Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 287  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Articlesmenu-bullet Search Instructions Online Submission Subscribe Etcetera Contact
 
  NAVIGATE here  
  ::   Search
  ::   Ahead of print
  ::   Current Issue
  ::   Submit Article 
  ::   Apply as Referee 
  ::   JPGM WriteCon 
  ::   Current Symposium 

 


This article has been cited by
1Improving and standardizing metabolic screening for people prescribed antipsychotic medication who are at risk of developing metabolic syndrome within the community mental health setting
Debbie Hackett,Catriona Fitzgerald
International Journal of Mental Health Nursing.2020;29(5)935
[DOI]
2The prevalence, risk factors and clinical correlates of diabetes mellitus in Chinese patients with schizophrenia
Lijuan Huo,Guangya Zhang,Xiang-Dong Du,Qiaqiufang Jia,Zheng-Kang Qian,Dachun Chen,Meihong Xiu,Fengchun Wu,Jair C. Soares,Xingbing Huang,Ryan M. Cassidy,Yuping Ning,Xiang Yang Zhang
Schizophrenia Research.2020;218(5)262
[DOI]
3Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome
Teodor T. Postolache,Laura Bosque-Plata,Serge Jabbour,Michael Vergare,Rongling Wu,Claudia Gragnoli
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics.2019;180(3)186
[DOI]
4Co-morbidities of mental disorders and chronic physical diseases in developing and emerging countries: a meta-analysis
Labanté Outcha Daré,Pierre-Emile Bruand,Daniel Gérard,Benoît Marin,Valerie Lameyre,Farid Boumédične,Pierre-Marie Preux
BMC Public Health.2019;19(1)186
[DOI]
5Evaluation of physical fitness parameters in patients with schizophrenia
Omer Ozbulut,Abdurrahman Genc,Erman Bagcioglu,Kerem Senol Coskun,Tolgahan Acar,Ozan Alper Alkoc,Hatice Karabacak,Umit Sener,Kagan Ucok
Psychiatry Research.2013;210(3)806
[DOI]
6Exploring mechanisms of increased cardiovascular disease risk with antipsychotic medications: Risperidone alters the cardiac proteomic signature in mice
Megan Beauchemin,Ramaz Geguchadze,Anyonya R. Guntur,Kathleen Nevola,Phuong T. Le,Deborah Barlow,Megan Rue,Calvin P.H. Vary,Christine W. Lary,Katherine J. Motyl,Karen L. Houseknecht
Pharmacological Research.2020;152(3)104589
[DOI]
7Prevalence and determinants of metabolic syndrome in patients with schizophrenia: A systematic review and meta-analysis of Indian studies
Suhas Ganesh,Abhishekh Hulegar Ashok,Chennaveerachari Naveen Kumar,Jagadish Thirthalli
Asian Journal of Psychiatry.2016;22(3)86
[DOI]
8Prevalence and determinants of metabolic syndrome in patients with schizophrenia: A systematic review and meta-analysis of Indian studies
Parmanand Kulhara,Sandeep Grover,Natasha Kate
Asian Journal of Psychiatry.2015;22(3)173
[DOI]
9Comparing self-efficacy and self-care behaviours between outpatients with comorbid schizophrenia and type 2 diabetes and outpatients with only type 2 diabetes
S-R. Chen,Y-P. Chien,C-M. Kang,C. Jeng,W-Y. Chang
Journal of Psychiatric and Mental Health Nursing.2014;21(5)414
[DOI]
10Exercise, diet and educational interventions for metabolic syndrome in persons with schizophrenia: A systematic review
Jothimani Gurusamy,Sailaxmi Gandhi,Dinakaran Damodharan,Venkatasubramanian Ganesan,Marimuthu Palaniappan
Asian Journal of Psychiatry.2018;36(5)73
[DOI]
11Schizophrenia in women and children: A selective review of literature from developing countries
Prabha S. Chandra,John Vijay Sagar Kommu,Vidyendran Rudhran
International Review of Psychiatry.2012;24(5)467
[DOI]
12The prevalence and mechanisms of metabolic syndrome in schizophrenia: a review
Evangelos Papanastasiou
Therapeutic Advances in Psychopharmacology.2013;3(1)33
[DOI]
13Metabolic syndrome among schizophrenia patients: Study from a rural community of south India
Channaveerachari Naveen Kumar,Jagadisha Thirthalli,K.K. Suresha,Udupi Arunachala,Bangalore N. Gangadhar
Asian Journal of Psychiatry.2013;6(6)532
[DOI]
14A meta-analysis of cardio-metabolic abnormalities in drug naďve, first-episode and multi-episode patients with schizophrenia versus general population controls
Davy Vancampfort,Martien Wampers,Alex J. Mitchell,Christoph U. Correll,Amber De Herdt,Michel Probst,Marc De Hert
World Psychiatry.2013;12(3)240
[DOI]
15Serum fatty acid patterns in patients with schizophrenia: a targeted metabonomics study
X Yang,L Sun,A Zhao,X Hu,Y Qing,J Jiang,C Yang,T Xu,P Wang,J Liu,J Zhang,L He,W Jia,C Wan
Translational Psychiatry.2017;7(7)e1176
[DOI]
16Kronik Ruhsal Hastaligi Olan Bireylerde Diyabet Yönetimi ve Psikiyatri Hemsiresinin Rolü
Sevecen ÇELIK INCE,Neslihan GÜNÜSEN
Dokuz Eylül Üniversitesi Hemsirelik Fakültesi Elektronik Dergisi.2020;7(7)195
[DOI]
17Metabolic abnormalities among people diagnosed with schizophrenia: a literature review and implications for mental health nurses
T. M. McDaid,S. Smyth
Journal of Psychiatric and Mental Health Nursing.2015;22(3)157
[DOI]
18The epidemiology of diabetes in psychotic disorders
Martha Ward,Benjamin Druss
The Lancet Psychiatry.2015;2(5)431
[DOI]
19The prevalence and predictors of type two diabetes mellitus in people with schizophrenia: a systematic review and comparative meta-analysis
B. Stubbs,D. Vancampfort,M. De Hert,A. J. Mitchell
Acta Psychiatrica Scandinavica.2015;132(2)144
[DOI]
Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow